For this purpose, examining MDF data from other cell fractions, such as lymphocytes and mature myeloid cells, in addition to blasts, and combined analysis of CD42b with CD41 or CD61 have been described to be useful in diagnosing AMKL [20, 23]. This evidence concerns the gene GP1BA and acute megakaryoblastic leukemia.